soul trial oral semaglutide cardiovascular outcomes results 2025 nejm Reduces CV Events in T2DM – (NEJM, Mar 2025) Relevant for: cardiology, diabetology, nephrology, internal medicine 🧪 T2DM + ASCVD/CKD 💊 Oral semaglutide 14 mg vs placebo 📉 SELECT Trial

A 2-tailed P value of less than 0.05 was considered statistically significant in all analyses

(no photo available) 96 tests $948 CSB-EL018969HU Prostatic binding protein ELISA Kit (PBP), Human For quantitative detection in human samples

& Gerken, G

Trimethylamine hydrochloride (CAS 593-81-7), TMAO (CAS 1184-78-7), -butyrobetaine [-BB, commercially available as 3-(Carboxypropyl)trimethylammonium chloride, CAS 6249-56-5], urolithin A (CAS 1143-70-0), urolithin B (CAS 1139-83-9), ellagic acid (CAS 476-66-4), trichloroacetic acid, dimethyl sulfoxide, glacial acetic acid, sulfatase (CAS 9016-17-5), -glucuronidase (CAS 9001-45-0), and heptafluorobutyric acid were purchased from Merck (Darmstadt, Germany)

In simple terms, prebiotics are the fuel, probiotics are potential helpers, and butyrate is the beneficial result

mL 1 of Hygromycin B (Life Technologies) for 2 weeks